Human Phenotype Ontology 
Grandparent Node:
expand
Abnormality of metabolism/homeostasis (HP:0001939)help
Parent Node:
expand
Abnormality of vitamin metabolism (HP:0100508)help
..Starting node
..expand
Abnormal circulating serine family amino acid concentration (HP:0010894)help
Term ID: 10894
Name: Abnormal circulating serine family amino acid concentration
Synonym: Abnormality of serine family amino acid metabolism
Definition: Any deviation from the normal concentration of a serine family amino acid in the blood circulation.
Comments:
Reference: HP:0010894
Genes and Diseases:
 
       Child Nodes:
........expandAbnormality of glycine metabolism (HP:0010895) help
................... HP:0002154 Hyperglycinemia
................... HP:0003108 Hyperglycinuria
................... HP:0010898 Abnormality of sarcosine metabolism
................... HP:0012277 Hypoglycinemia
........expandAbnormality of serine metabolism (HP:0012278) help
................... HP:0012279 Hyposerinemia

 Sister Nodes: 
..expandAbnormality of vitamin A metabolism (HP:0008372) help
..expandAbnormality of vitamin B metabolism (HP:0004340) help
..expandAbnormality of vitamin C metabolism (HP:0100509) help
..expandAbnormality of vitamin D metabolism (HP:0100511) help
..expandAbnormality of vitamin E metabolism (HP:0100514) help
..expandAbnormality of vitamin K metabolism (HP:0100831) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0ALDH4A1 CL E G H8659406ORPHA:79101Hyperprolinemia type 274
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0AMT CL E G H275473OMIM:605899Glycine encephalopathy56
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0BOLA3 CL E G H38896224415OMIM:614299Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia14
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0COX8A CL E G H13512294OMIM:619059MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 15; MC4DN151
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0GCSH CL E G H26534208OMIM:605899Glycine encephalopathy5
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0GLDC CL E G H27314313OMIM:605899Glycine encephalopathy166
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0GLRX5 CL E G H5121820134ORPHA:401866Childhood-onset spasticity with hyperglycinemia17
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0GLRX5 CL E G H5121820134OMIM:616859Spasticity, childhood-onset, with hyperglycinemia17
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0GLYCTK CL E G H13215824247OMIM:220120D-GLYCERIC ACIDURIA6
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0GLYCTK CL E G H13215824247ORPHA:941D-glyceric aciduria6
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0IRF6 CL E G H36646121ORPHA:1300Autosomal dominant popliteal pterygium syndrome99
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0MMAA CL E G H16678518871OMIM:251100Methylmalonic aciduria, Cbla type113
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0MMAB CL E G H32662519331OMIM:251110Methylmalonic aciduria, Cblb type127
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0MMUT CL E G H45947526OMIM:251000Methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0NFS1 CL E G H905415910OMIM:619386COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52; COXPD525
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0NFU1 CL E G H2724716287OMIM:605711Multiple mitochondrial dysfunctions syndrome 134
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0PCCA CL E G H50958653OMIM:606054Propionic acidemia96
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0PCCB CL E G H50968654OMIM:606054Propionic acidemia92
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0PET117 CL E G H10030375540045OMIM:619063MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 19; MC4DN19
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0PHGDH CL E G H262278923ORPHA:793513-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form37
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0PNPO CL E G H5516330260ORPHA:79096Pyridoxal phosphate-responsive seizures92
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0PSAT1 CL E G H2996819129OMIM:610992Phosphoserine aminotransferase deficiency27
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0PSAT1 CL E G H2996819129ORPHA:284417Phosphoserine aminotransferase deficiency, infantile/juvenile form27
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0PSPH CL E G H57239577ORPHA:793503-phosphoserine phosphatase deficiency, infantile/juvenile form54
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0SARDH CL E G H175710536ORPHA:3129Sarcosinemia4
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0SLC25A13 CL E G H1016510983ORPHA:247598Neonatal intrahepatic cholestasis due to citrin deficiency82
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0SLC30A10 CL E G H5553225355ORPHA:309854Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome42
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0SLC7A7 CL E G H905611065ORPHA:470Lysinuric protein intolerance104
HP:0010894HP:0010894Abnormal circulating serine family amino acid concentration0SUCLG1 CL E G H880211449OMIM:245400Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)60
HP:0010894HP:0010895Abnormal circulating glycine concentration1ALDH4A1 CL E G H8659406ORPHA:79101Hyperprolinemia type 274
HP:0010894HP:0010895Abnormal circulating glycine concentration1AMT CL E G H275473OMIM:605899Glycine encephalopathy56
HP:0010894HP:0010895Abnormal circulating glycine concentration1BOLA3 CL E G H38896224415OMIM:614299Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia14
HP:0010894HP:0010895Abnormal circulating glycine concentration1COX8A CL E G H13512294OMIM:619059MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 15; MC4DN151
HP:0010894HP:0010895Abnormal circulating glycine concentration1GCSH CL E G H26534208OMIM:605899Glycine encephalopathy5
HP:0010894HP:0010895Abnormal circulating glycine concentration1GLDC CL E G H27314313OMIM:605899Glycine encephalopathy166
HP:0010894HP:0010895Abnormal circulating glycine concentration1GLRX5 CL E G H5121820134ORPHA:401866Childhood-onset spasticity with hyperglycinemia17
HP:0010894HP:0010895Abnormal circulating glycine concentration1GLRX5 CL E G H5121820134OMIM:616859Spasticity, childhood-onset, with hyperglycinemia17
HP:0010894HP:0010895Abnormal circulating glycine concentration1GLYCTK CL E G H13215824247OMIM:220120D-GLYCERIC ACIDURIA6
HP:0010894HP:0010895Abnormal circulating glycine concentration1GLYCTK CL E G H13215824247ORPHA:941D-glyceric aciduria6
HP:0010894HP:0010895Abnormal circulating glycine concentration1IRF6 CL E G H36646121ORPHA:1300Autosomal dominant popliteal pterygium syndrome99
HP:0010894HP:0010895Abnormal circulating glycine concentration1MMAA CL E G H16678518871OMIM:251100Methylmalonic aciduria, Cbla type113
HP:0010894HP:0010895Abnormal circulating glycine concentration1MMAB CL E G H32662519331OMIM:251110Methylmalonic aciduria, Cblb type127
HP:0010894HP:0010895Abnormal circulating glycine concentration1MMUT CL E G H45947526OMIM:251000Methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
HP:0010894HP:0010895Abnormal circulating glycine concentration1NFS1 CL E G H905415910OMIM:619386COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52; COXPD525
HP:0010894HP:0010895Abnormal circulating glycine concentration1NFU1 CL E G H2724716287OMIM:605711Multiple mitochondrial dysfunctions syndrome 134
HP:0010894HP:0010895Abnormal circulating glycine concentration1PCCA CL E G H50958653OMIM:606054Propionic acidemia96
HP:0010894HP:0010895Abnormal circulating glycine concentration1PCCB CL E G H50968654OMIM:606054Propionic acidemia92
HP:0010894HP:0010895Abnormal circulating glycine concentration1PET117 CL E G H10030375540045OMIM:619063MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 19; MC4DN19
HP:0010894HP:0010895Abnormal circulating glycine concentration1PHGDH CL E G H262278923ORPHA:793513-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form37
HP:0010894HP:0012278Abnormal circulating serine concentration1PHGDH CL E G H262278923ORPHA:793513-phosphoglycerate dehydrogenase deficiency, infantile/juvenile form37
HP:0010894HP:0010895Abnormal circulating glycine concentration1PNPO CL E G H5516330260ORPHA:79096Pyridoxal phosphate-responsive seizuresHP:0040283 - Occasional92
HP:0010894HP:0010895Abnormal circulating glycine concentration1PSAT1 CL E G H2996819129OMIM:610992Phosphoserine aminotransferase deficiency27
HP:0010894HP:0012278Abnormal circulating serine concentration1PSAT1 CL E G H2996819129OMIM:610992Phosphoserine aminotransferase deficiency27
HP:0010894HP:0010895Abnormal circulating glycine concentration1PSAT1 CL E G H2996819129ORPHA:284417Phosphoserine aminotransferase deficiency, infantile/juvenile form27
HP:0010894HP:0012278Abnormal circulating serine concentration1PSAT1 CL E G H2996819129ORPHA:284417Phosphoserine aminotransferase deficiency, infantile/juvenile form27
HP:0010894HP:0012278Abnormal circulating serine concentration1PSPH CL E G H57239577ORPHA:793503-phosphoserine phosphatase deficiency, infantile/juvenile form54
HP:0010894HP:0010898Abnormal circulating sarcosine concentration1SARDH CL E G H175710536ORPHA:3129Sarcosinemia4
HP:0010894HP:0012278Abnormal circulating serine concentration1SLC25A13 CL E G H1016510983ORPHA:247598Neonatal intrahepatic cholestasis due to citrin deficiencyHP:0040283 - Occasional82
HP:0010894HP:0010895Abnormal circulating glycine concentration1SLC30A10 CL E G H5553225355ORPHA:309854Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome42
HP:0010894HP:0012278Abnormal circulating serine concentration1SLC7A7 CL E G H905611065ORPHA:470Lysinuric protein intoleranceHP:0040282 - Frequent104
HP:0010894HP:0010895Abnormal circulating glycine concentration1SLC7A7 CL E G H905611065ORPHA:470Lysinuric protein intolerance104
HP:0010894HP:0010895Abnormal circulating glycine concentration1SUCLG1 CL E G H880211449OMIM:245400Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)60
HP:0010894HP:0500138Hyperserinemia2 CL E G H
HP:0010894HP:0002154Hyperglycinemia2ALDH4A1 CL E G H8659406ORPHA:79101Hyperprolinemia type 2HP:0040282 - Frequent74
HP:0010894HP:0002154Hyperglycinemia2AMT CL E G H275473OMIM:605899Glycine encephalopathy.56
HP:0010894HP:0002154Hyperglycinemia2BOLA3 CL E G H38896224415OMIM:614299Multiple mitochondrial dysfunctions syndrome 2 with hyperglycinemia14
HP:0010894HP:0002154Hyperglycinemia2COX8A CL E G H13512294OMIM:619059MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 15; MC4DN151
HP:0010894HP:0002154Hyperglycinemia2GCSH CL E G H26534208OMIM:605899Glycine encephalopathy.5
HP:0010894HP:0002154Hyperglycinemia2GLDC CL E G H27314313OMIM:605899Glycine encephalopathy.166
HP:0010894HP:0002154Hyperglycinemia2GLRX5 CL E G H5121820134ORPHA:401866Childhood-onset spasticity with hyperglycinemia17
HP:0010894HP:0002154Hyperglycinemia2GLRX5 CL E G H5121820134OMIM:616859Spasticity, childhood-onset, with hyperglycinemia17
HP:0010894HP:0002154Hyperglycinemia2GLYCTK CL E G H13215824247ORPHA:941D-glyceric aciduriaHP:0040282 - Frequent6
HP:0010894HP:0002154Hyperglycinemia2GLYCTK CL E G H13215824247OMIM:220120D-GLYCERIC ACIDURIA6
HP:0010894HP:0002154Hyperglycinemia2IRF6 CL E G H36646121ORPHA:1300Autosomal dominant popliteal pterygium syndrome99
HP:0010894HP:0002154Hyperglycinemia2MMAA CL E G H16678518871OMIM:251100Methylmalonic aciduria, Cbla type.113
HP:0010894HP:0002154Hyperglycinemia2MMAB CL E G H32662519331OMIM:251110Methylmalonic aciduria, Cblb type.127
HP:0010894HP:0002154Hyperglycinemia2MMUT CL E G H45947526OMIM:251000Methylmalonic aciduria due to methylmalonyl-coa mutase deficiency.
HP:0010894HP:0002154Hyperglycinemia2NFS1 CL E G H905415910OMIM:619386COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 52; COXPD525
HP:0010894HP:0002154Hyperglycinemia2NFU1 CL E G H2724716287OMIM:605711Multiple mitochondrial dysfunctions syndrome 134
HP:0010894HP:0002154Hyperglycinemia2PCCA CL E G H50958653OMIM:606054Propionic acidemia.96
HP:0010894HP:0002154Hyperglycinemia2PCCB CL E G H50968654OMIM:606054Propionic acidemia.92
HP:0010894HP:0002154Hyperglycinemia2PET117 CL E G H10030375540045OMIM:619063MITOCHONDRIAL COMPLEX IV DEFICIENCY, NUCLEAR TYPE 19; MC4DN19
HP:0010894HP:0012277Hypoglycinemia2PHGDH CL E G H262278923ORPHA:793513-phosphoglycerate dehydrogenase deficiency, infantile/juvenile formHP:0040281 - Very frequent37
HP:0010894HP:0012279Hyposerinemia2PHGDH CL E G H262278923ORPHA:793513-phosphoglycerate dehydrogenase deficiency, infantile/juvenile formHP:0040281 - Very frequent37
HP:0010894HP:0012277Hypoglycinemia2PSAT1 CL E G H2996819129OMIM:610992Phosphoserine aminotransferase deficiency.27
HP:0010894HP:0012279Hyposerinemia2PSAT1 CL E G H2996819129OMIM:610992Phosphoserine aminotransferase deficiency.27
HP:0010894HP:0002154Hyperglycinemia2PSAT1 CL E G H2996819129ORPHA:284417Phosphoserine aminotransferase deficiency, infantile/juvenile formHP:0040281 - Very frequent27
HP:0010894HP:0012279Hyposerinemia2PSAT1 CL E G H2996819129ORPHA:284417Phosphoserine aminotransferase deficiency, infantile/juvenile formHP:0040281 - Very frequent27
HP:0010894HP:0012279Hyposerinemia2PSPH CL E G H57239577ORPHA:793503-phosphoserine phosphatase deficiency, infantile/juvenile formHP:0040282 - Frequent54
HP:0010894HP:0010896Hypersarcosinemia2SARDH CL E G H175710536ORPHA:3129SarcosinemiaHP:0040280 - Obligate4
HP:0010894HP:0002154Hyperglycinemia2SLC30A10 CL E G H5553225355ORPHA:309854Cirrhosis-dystonia-polycythemia-hypermanganesemia syndromeHP:0040283 - Occasional42
HP:0010894HP:0002154Hyperglycinemia2SLC7A7 CL E G H905611065ORPHA:470Lysinuric protein intoleranceHP:0040282 - Frequent104
HP:0010894HP:0002154Hyperglycinemia2SUCLG1 CL E G H880211449OMIM:245400Mitochondrial DNA depletion syndrome 9 (encephalomyopathic type with methylmalonic aciduria)60
HP:0010894HP:0008288Nonketotic hyperglycinemia3GLRX5 CL E G H5121820134ORPHA:401866Childhood-onset spasticity with hyperglycinemiaHP:0040281 - Very frequent17
HP:0010894HP:0008288Nonketotic hyperglycinemia3GLYCTK CL E G H13215824247OMIM:220120D-GLYCERIC ACIDURIA.6
HP:0010894HP:0008288Nonketotic hyperglycinemia3GLYCTK CL E G H13215824247ORPHA:941D-glyceric aciduriaHP:0040283 - Occasional6
HP:0010894HP:0008288Nonketotic hyperglycinemia3IRF6 CL E G H36646121ORPHA:1300Autosomal dominant popliteal pterygium syndromeHP:0040282 - Frequent99


Genes (26) :ALDH4A1 AMT BOLA3 COX8A GCSH GLDC GLRX5 GLYCTK IRF6 MMAA MMAB MMUT NFS1 NFU1 PCCA PCCB PET117 PHGDH PNPO PSAT1 PSPH SARDH SLC25A13 SLC30A10 SLC7A7 SUCLG1

Diseases (26) :ORPHA:79101 OMIM:605899 OMIM:614299 OMIM:619059 ORPHA:401866 OMIM:616859 OMIM:220120 ORPHA:941 ORPHA:1300 OMIM:251100 OMIM:251110 OMIM:251000 OMIM:619386 OMIM:605711 OMIM:606054 OMIM:619063 ORPHA:79351 ORPHA:79096 OMIM:610992 ORPHA:284417 ORPHA:79350 ORPHA:3129 ORPHA:247598 ORPHA:309854 ORPHA:470 OMIM:245400
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.